Atovaquone Suspension
Product Images NDC 50268-119

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Atovaquone (NDC 50268-119). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (119 12)

Label for Atovaquone Oral Suspension USP, 750 mg/5 mL strength. The label indicates this is a prescription product with 20 units of 5 mL each. It includes usage instructions, storage conditions (15° to 25°C), a warning not to freeze, and advises shaking gently before use. Manufactured for AvPAK, Pulaski, TN, with barcode and QR code present.*

FDA Label Image

Structure (Atovaquone Oral Suspension 1)

Chemical structure of atovaquone depicting the molecular framework including a quinone core, cyclohexyl ring, and chlorophenyl group, consistent with the active ingredient atovaquone.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.